The Universal Medica’s “Chinese Pharma&Biotech Press Review” (CPBPR) gives you key information to succeed for business in China.

The CPBPR is published weekly with essential information from the latest pharmaceutics, biotechnologies and healthcare news from China.

Accurate, concise and practical, the CPBPR is a weekly e-newsletter that selects, organizes and summarizes the main activities of the pharmaceutical and biotechnological market in China.

The CPBPR is structured around several major topics: pharmaceuticals information, biotechnology, scientific research, events. It provides relevant overall visibility to be informed of the main trends and latest market opportunities, diseases, health products and information on the industry conventions and conferences in China and Asia.

Written by a team of scientific and marketing experts based in Shanghai, "China Pharma&Biotech Press Review" is a strategic tool that delivers quality information and not-to-be-missed opportunities to predict the market growth of China and Asia.

With its variety of reference sources, the CPBPR is a strategic and reliable competitive intelligence tool that reduces the gap between the Chinese market and foreign companies.

Download an example of CPBPR

For more information, please fill in this form  

2011 book of chinese pharma and healthcare press review

2011 press review on Chinese pharma, biotech, R&D, events and healthcare news synthesized in a book.

Main features:
•    More than 400 selected articles on healthcare
•    More than 200 selected articles on pharmaceuticals
•    More than 60 selected articles on biotechnology
•    20 major scientific events occurred in China
•    A top selection of articles: major events of the Chinese market that occurred in 2011
•    Selected figures and charts to complete 2011 major information
•    Market outlook
And more features…

Interested? To get more information or to order it, contact us.

Special 50% discount for any order before the 19th February 2012:  690€  instead of 1390€

Based in Shanghai since 2005, Universal Medica has developed a network of quality relationship with many local health partners.

Our Shanghaï team, with dual expertise in marketing and science, is working closely with our partners in the preparation of study reports on issues and specificities of the health industry in China and integrates practical advice and recommendations thanks to its expertise in the pharmaceutical industry and knowledge of the Chinese market.

New Report - December 2011 - “Drug Safety in China”

We are glad to inform you that our new market analysis report “Drug Safety in China” has now been published.

Be aware of the new MoH rules, from July 2011, tightening the ADR reporting and monitoring environment, for your company to be in line with the Chinese SFDA requirements…

Download the brochure

2010 Report - “Clinical trials in China”

Clinical trial industry has been constantly expanding since 2000, and it has become one of the economic drivers of China.
This report provides key information on how to conduct clinical trial in China, including:
•    Chinese market dynamics
•    Regulatory environment and key regulatory changes, procedures
•    Clinical study design and planning,
•    Market drivers and market barriers of conducting clinical trials in China
•    Main actors of the market (including identification sheets of main CROs operating in China now).

It also helps foreign companies to detect opportunities on the market.

Download the brochure

In order to fit your needs, we seek your opinion about the choice of the next reports topics: please fill this form .

Our custom made reports

Do you need specific information?

Universal Medica China offers customized reports to meet your problems.

For more information, please contact us by email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

BD Tool Box is a database gathering more than 1000 contacts from:

• CRO - CEOs,Top Management Directors
  
• Healthcare Companies (Pharmaceutical, Biotechnology, Medical Equipment) - CEOs, Marketing, Sales, BD Managers
• Healthcare Institutions (Hospital, Clinic) - Directors, Chief pharmacist, Physicians, KOL
  

BD Tool box will give you a direct access to the targeted manager thus improving your Business Development efficiency.